Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2

A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fang, Cai, Zhao-bin, Huang, Jin-song, Niu, Hai-ying, Yu, Wen-yan, Zhang, Yan, Yan, Ting-bo, Chen, Chen, Liu, Yuan, Xu, Ai-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406422/
https://www.ncbi.nlm.nih.gov/pubmed/32807688
http://dx.doi.org/10.1016/j.jmii.2020.07.017
Descripción
Sumario:A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.

Ejemplares similares